We are live on ! Find out more
OLMA icon

Olema Pharmaceuticals
OLMA

200 hedge funds and large institutions have $2.27B invested in Olema Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 87 funds opening new positions, 55 increasing their positions, 39 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

625% more first-time investments, than exits

New positions opened: 87 | Existing positions closed: 12

450% more funds holding in top 10

Funds holding in top 10: 2 → 11 (+9)

239% more capital invested

Capital invested by funds: $668M → $2.27B (+$1.6B)

76% more call options, than puts

Call options by funds: $30.8M | Put options by funds: $17.5M

59% more funds holding

Funds holding: 126 → 200 (+74)

41% more repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 39

32.66% more ownership

Funds ownership: 99.49% → 132.15% (+33%)

Holders
200
Holders Change
+74
Holders Change %
+58.73%
% of All Funds
2.43%
Holding in Top 10
11
Holding in Top 10 Change
+9
Holding in Top 10 Change %
+450%
% of All Funds
0.13%
New
87
Increased
55
Reduced
39
Closed
12
Calls
$30.8M
Puts
$17.5M
Net Calls
+$13.3M
Net Calls Change
+$7.65M

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
+$88.9M
2
SL
Siren LLC
Connecticut
+$58.7M
3
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$55.6M
4
CAM
Cormorant Asset Management
Massachusetts
+$48.9M
5
RCM
RA Capital Management
Massachusetts
+$46.3M

Top Sellers

1
DTC
Deep Track Capital
Connecticut
-$34M
2
Pictet Asset Management
Pictet Asset Management
Switzerland
-$20.2M
3
Ameriprise
Ameriprise
Minnesota
-$16.8M
4
UBS Group
UBS Group
Switzerland
-$16M
5
Morgan Stanley
Morgan Stanley
New York
-$15.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
PNC Financial Services Group
176
PNC Financial Services Group
Pennsylvania
$13.8K -$2.95K -166 -23%
US Bancorp
177
US Bancorp
Minnesota
$13.4K +$9.57K +538 New
Osaic Holdings
178
Osaic Holdings
Arizona
$11.8K +$8.43K +474 New
UBS AM
179
UBS AM
Illinois
$10.3K +$7.33K +412 New
PWA
180
Physician Wealth Advisors
Utah
$9.78K – – –
AF
181
Allworth Financial
California
$9.3K +$6.62K +372 New
SPIA
182
Steward Partners Investment Advisory
New York
$9K +$6.41K +360 New
Optiver Holding
183
Optiver Holding
Netherlands
$8.47K +$1.83K +103 +44%
Daiwa Securities Group
184
Daiwa Securities Group
Japan
$6K – – –
RIL
185
Rothschild Investment LLC
Illinois
$5.67K +$36 +2 +0.9%
FFA
186
Farther Finance Advisors
California
$4.5K +$2.67K +150 +500%
Rockefeller Capital Management
187
Rockefeller Capital Management
New York
$3.75K +$2.67K +150 New
PFBT
188
Parkside Financial Bank & Trust
Missouri
$3.38K – – –
GWM
189
Greenline Wealth Management
Florida
$2.77K +$1.98K +111 New
TWD
190
True Wealth Design
Ohio
$1.52K – – –
SS
191
SBI Securities
Japan
$1.52K +$178 +10 +20%
AEPWM
192
Atlantic Edge Private Wealth Management
Florida
$1.25K +$890 +50 New
CA
193
Clearstead Advisors
Ohio
$1.07K +$765 +43 New
HBW
194
Hazlett, Burt & Watson
West Virginia
$1K +$890 +50 New
HC
195
Hurley Capital
New York
$725 +$516 +29 New
IA
196
IFP Advisors
Florida
$150 – – –
HNB
197
Huntington National Bank
Ohio
$25 – – –
HFS
198
Hughes Financial Services
Virginia
$25 +$18 +1 New
AWM
199
Activest Wealth Management
Florida
$13 +$18 +1 New
DTC
200
Deep Track Capital
Connecticut
– -$34M -3,470,172 Closed
5 6 7
8
9

OLMA Hedge Fund Activity: Q4 2025 in Review

200 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Olema Pharmaceuticals (OLMA) for Q4 2025, worth a combined $2.27B — up 239% from $668M a quarter earlier.

Buyers outnumbered sellers: 87 funds opened new OLMA positions and 12 closed out — a net gain of 75 holders — while 55 added to existing stakes and 39 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $88.9M. The largest seller was Deep Track Capital, exiting entirely with an estimated $34M sold.

  • 200 institutional investors held Olema Pharmaceuticals (OLMA) as of Q4 2025, up from 126 in Q3 2025.
  • Funds reported $2.27B of Olema Pharmaceuticals stock for Q4 2025, up 239% quarter-over-quarter.
  • 87 funds opened new Olema Pharmaceuticals positions in Q4 2025 and 12 closed out, a net change of +75 holders.
  • The largest Olema Pharmaceuticals buyer in Q4 2025 was Fidelity Investments, an estimated $88.9M added.
  • The largest Olema Pharmaceuticals seller in Q4 2025 was Deep Track Capital, an estimated $34M sold.

Based on aggregated 13F filings for Q4 2025.